Rasaense e Moholo
Wenqiang Yu, Ph.D.
●Rasaense e Moholo oa Lenaneo la Naha la "973";
●Moprofesa ea khethiloeng ka ho khetheha bakeng sa Lenaneo la Litsebi tsa Chang Jiang;
●PI, Setsi sa Epigenetics, Institute of Biomedical Sciences Fudan University;
●Mofuputsi ea khethiloeng ka ho khetheha le Mookameli oa Ngaka oa Univesithi ea Fudan;
●Moetapele oa Komiti ea Setsebi ea Methylation Marker ea Komiti ea Li-Tumor Marker ea Mokhatlo oa Chaena oa Anti-Cancer.
Ka 1989, o ile a fumana mangolo Univesithing ea Bongaka ea Bone ea Sesole 'me a fumana Bachelor's Degree in Medicine;
Ka 2001, o ile a fumana lengolo la hae la Doctorate ho tsoa Univesithing ea Bone ea Sesole sa Bongaka;
Ho tloha 2001-2004, o ile a fumana Postdoctoral Lefapheng la Ntlafatso le Liphatsa tsa lefutso, Uppsala University, Sweden;
Ho tloha 2004-2007, o fumane Postdoctoral ho Hopkins University School of Medicine, United States;
Hajoale, Moprofesa Yu ke PI le molekane oa lipatlisiso oa Institutes of Biomedical Sciences of Fudan University, le Motlatsi oa Motsamaisi oa Phethahatso oa Setsi sa Genomics le Epigenomics sa Univesithi ea Fudan.Liphihlello tsa hae tsa lipatlisiso li ne li phatlalalitsoe likoranteng tsa machaba tse phahameng tsa thuto tse kang,Tlhaho, Nature GeneticsleJAMA.
e hlahisitsoe likoranteng tsa machaba tse phahameng tsa thuto tse kang Nature, Nature Genetics le JAMA, tse nang le tšusumetso e phahameng ka ho fetisisa ea lintlha tse 38.1.
CEO
Lin Hua
Bachelor of Economics ea Shanghai JiaoUnivesithi ea Tong.O ile a sebetsa e le Mookameli oa Phethahatso oa Lefapha la Likhampani le Ngotsoeng la Guosen Securities, molekane oa XIANGDU CAPITAL, molekane ea thehileng oa CHOBE CAPITAL.Joaloka moetapele oa sehlopha, o khothalelitse ho tsetela lik'hamphani tse 'maloa tse atlehileng.
ObiO(688238): Moetsi oa CGT CDMO ea nang le bokhoni bo boholo ka ho fetisisa;
Novoprotein(688137): morekisi oa thepa e tala o shebane le protheine e nchafalitsoeng;
Leadsynbio: k'hamphani e etellang pele ho baeloji ea maiketsetso;
SinoBay: likhoebo tse lebisitsoeng ho kalafo ea tumor
Quectel(603236): khoebo e kholo ka ho fetisisa lefatšeng ea puisano e se nang mohala
XinpelTek: tsepamisa maikutlo ho khoebo ea chip ea PA RF e se nang mohala;
DGene: tsepamisa maikutlo ho khoebo ea dijithale ea 3D
Video++: khoebo ea unicorn sebakeng sa AI
Ka lilemo tse fetang leshome 'marakeng oa capital, Mme Hua o bokelletse boiphihlelo bo botle taolong ea khoebo le matsete.
Motsamaisi oa R&D
Wei Li, Ph.D.
Ngaka Li o sebelitse e le Mofuputsi ea Kopantseng Setsing sa Biological Science Fudan University ka lilemo tse leshome.O ile a okamela merero ea lipatlisiso tse 3 ho kenyeletsa National Natural Science Foundation ea Chaena,morero oa lipatlisiso o ikemetseng oa ho hlahisa litalentale etc.O ile a boela a kenya letsoho mererong e mengata ea naha, ho akarelletsa le morero oa National 973, Project Key of National Natural Science Foundation joalo-joalo.O phatlalalitse lipampiri tse 16 tsa SCI joalo ka sengoli sa pele kapa sengoli se ngollanang hoPatlisiso ea Genome, eBiomedicine, Asiti ea Nyutlelie Lipatlisiso le joalo-joalo.(Aggregate Impact Factor 158.97).
Lithahasello tsa mantlha tsa lipatlisiso:
1. Nts'etsopele ea li-algorithms tsa epigenetic le lithuto tse ngata tsa omics tsa tumor pathogenesis.Phapang e le 'ngoe ea motheo e rarollang sethala sa tlhahlobo ea tatellano ea DNA methylation ea genome-wide (WGPS algorithm) e thehiloe qalong.Ebe 'mapa oa pele oa genome-wide DNA methylation oa lisele tsa sebete sa motho o se o fumanoe.Ho sa le joalo, o fane ka mokhoa o mocha oa ho khutsisa liphatsa tsa lefutso tsa tumor ho pono ea epigenetics.
2. Hlakola li-biomarker tse tloaelehileng tsa boitšoaro bo bobe mefuteng e mengata ea kankere ka lintlha tse ngata tsa omics.Ho latela mekhoa ea WGPS, re ile ra hlahloba matšoao a khethehileng a hypermethylation lipakeng tsa lihlahala le tse tloaelehileng.
3. Lipatlisiso mabapi le pathogenesis ea gene transcriptional activation ka NamiRNA: Sehlopha sa nuclear miRNA, eo re e rehileng NamiRNA (Nuclear Activating miRNA).
Moenjiniere oa R&D oa Bongaka
Meigui Wang, Ph.D.
Ngaka Wang o ile a fumana Ph.D.lengolo la thuto ea bongaka ho tsoa Univesithing ea Bongaka ea Boroa ka 2019. O ile a tsoela pele ho latela lithupelo tsa hae tsa boemo bo botle Sepetleleng sa Boraro se Kopanetsoeng sa Univesithi ea Sun Yat-sen(2019-2021).Thahasello ea hae ea bongaka ke tlhahlobo le kalafo ea mofets'e oa hlooho le molala joalo ka mofetše oa laryngeal le nasopharyngeal carcinoma.Lithahasello tsa hae tsa lipatlisiso li shebane le tlhahlobo ea pele ea nasopharyngeal carcinoma.
Moenjiniere oa R&D oa Bongaka
Yaping Dong, Ph.D.
Ngaka Dong o ile a fumana Ph.D.tekanyo ea meriana ea bongaka e tsoang Univesithing ea Bongaka ea Fujian ka 2020, 'me a etsa lipatlisiso tsa morao-rao setsing sa Kankere sa Fudan University Shanghai ho tloha 2020 ho isa 2022. Joaloka monkakarolo ea ka sehloohong, o ile a kenya letsoho Merero e mengata ea Sechaba, ho kenyeletsoa Lekala la Saense le Theknoloji Lenaneo la Bohlokoa la " Tsoelo-pele e Ncha ea Bohlokoa ea Lithethefatsi ", National Natural Science Foundation ea Chaena joalo-joalo.O phatlalalitse lipampiri tse 'maloa tsa boleng bo holimo ho Acta Pharmaceutica Sinica B, Acta Pharmacologica Sinica le Radiation Oncology.